Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
TCR² Therapeutics revenue
TCR² Therapeutics's revenue is $661.1 million.
What is TCR² Therapeutics's revenue?
- TCR² Therapeutics has 118 employees, and the revenue per employee ratio is $5,602,153.
- TCR² Therapeutics peak revenue was $661.1M in 2024.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
TCR² Therapeutics financial information
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 118 |
| Date Founded | 2015 |
| Headquarters | Cambridge, Massachusetts |
| Revenue | $661.1M |
| Net Income | -$151,822,000 |
| Tax Rate | -0.0% |
| Total Assets | $208,236,000 |
| Ticker | TCRR |
TCR² Therapeutics jobs you might like
TCR² Therapeutics financing
TCR² Therapeutics received early financing of $3.8M on 2016-01-29.
| Series | Round size | Date |
|---|---|---|
| Series A | $3.8M | 01/2016 |
| Series A | $44.5M | 12/2016 |
| Series B | $125M | 03/2018 |
TCR² Therapeutics investors
| Investors | Security type |
|---|---|
| MPM Capital | Series A |
| UBS Asset Management | Series A |
| F2 Ventures Ltd | Series A |
| Cathay Capital | Series B |
| MPM Capital | Series B |
| UBS Asset Management | Series B |
| ArrowMark Partners | Series B |
| F2 Ventures Ltd | Series B |
| Hillhouse Capital Group | Series B |
| curative ventures | Series B |
| Alexandria Venture Investments | Series B |
| Redmile Group | Series B |
| Sirona Capital | Series B |
| Haitong International Securities Group Limited | Series B |
| Syno Capital | Series B |
| Mirae Asset Global Investments | Series B |
| 6 Dimensions Capital | Series B |
TCR² Therapeutics competitors
TCR² Therapeutics's top competitor, Arvinas Inc., earned an annual revenue of $263.4M.
TCR² Therapeutics's smallest competitor is Allogene Therapeutics with revenue of $95.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Eureka Therapeutics | - | $500,000 | 50 | - |
| BioTime | - | $3.4M | 101 | - |
| Allogene Therapeutics | - | $95,000 | 289 | - |
| C4 Therapeutics | - | $35.6M | 300 | - |
| Leap Therapeutics | - | $1.5M | 30 | - |
| Adaptimmune | - | $178.0M | 452 | - |
| Arcellx | - | $107.9M | 1 | - |
| WindMIL Therapeutics | - | $530,000 | 30 | - |
| Arvinas Inc. | - | $263.4M | 83 | - |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
TCR² Therapeutics highest paying jobs
Zippia gives an in-depth look into the details of TCR² Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about TCR² Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at TCR² Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by TCR² Therapeutics. The data presented on this page does not represent the view of TCR² Therapeutics and its employees or that of Zippia.
TCR² Therapeutics may also be known as or be related to TCR2, TCR2 THERAPEUTICS INC., TCR2 Therapeutics Inc., TCR² Therapeutics and Tcr2 Therapeutics Inc.